American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Christopher G AzzoliAmerican Society of Clinical Oncology

Abstract

The purpose of this article is to provide updated recommendations for the treatment of patients with stage IV non-small-cell lung cancer. A literature search identified relevant randomized trials published since 2002. The scope of the guideline was narrowed to chemotherapy and biologic therapy. An Update Committee reviewed the literature and made updated recommendations. One hundred sixty-two publications met the inclusion criteria. Recommendations were based on treatment strategies that improve overall survival. Treatments that improve only progression-free survival prompted scrutiny of toxicity and quality of life. For first-line therapy in patients with performance status of 0 or 1, a platinum-based two-drug combination of cytotoxic drugs is recommended. Nonplatinum cytotoxic doublets are acceptable for patients with contraindications to platinum therapy. For patients with performance status of 2, a single cytotoxic drug is sufficient. Stop first-line cytotoxic chemotherapy at disease progression or after four cycles in patients who are not responding to treatment. Stop two-drug cytotoxic chemotherapy at six cycles even in patients who are responding to therapy. The first-line use of gefitinib may be recommended for patients...Continue Reading

References

Aug 1, 1997·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·C F QuirtL Ginsburg
Jun 12, 1998·JAMA : the Journal of the American Medical Association·J C WeeksR S Phillips
Jun 19, 1998·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·S Thongprasert
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark A SocinskiMerrill S Kies
Mar 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig C EarleJane C Weeks
Nov 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G V ScagliottiUNKNOWN Italian Lung Cancer Project
Dec 25, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·E MassarelliR S Herbst
Feb 6, 2003·British Journal of Cancer·S NegoroUNKNOWN CPT-11 Lung Cancer Study Group West
Jul 3, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frank FossellaChandra P Belani
Aug 21, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Petr ZatloukalMilan Kůta
Aug 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V AlberolaUNKNOWN Spanish Lung Cancer Group
Dec 31, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Adriano PaccagnellaUNKNOWN GSTVP (Gruppo di Studio Tumori Polmonari del Veneto)
Feb 24, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rafael RosellUNKNOWN Spanish Lung Cancer Group
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe GiacconeDavid H Johnson
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstDavid H Johnson
May 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nasser HannaPaul A Bunn
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David H JohnsonFairooz Kabbinavar
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E LaackUNKNOWN German and Swiss Lung Cancer Study Group
Jun 19, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G P StathopoulosA Gerogianni
Jul 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vassilis GeorgouliasAthanasios Alegakis
Jul 29, 2004·JAMA : the Journal of the American Medical Association·Catherine DelbaldoJean-Pierre Pignon
Aug 25, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Katsuyuki HottaMitsune Tanimoto
Sep 28, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Vanesa GregorcEugenio Villa
Nov 20, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K HottaM Tanimoto
Dec 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rogerio C LilenbaumMark R Green
Feb 25, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vassilis GeorgouliasDora Chatzidaki
Feb 25, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giannicola D'AddarioFrances A Shepherd
Mar 3, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-L PujolC Clary
Mar 3, 2005·Journal of the National Cancer Institute·Hisayuki ShigematsuAdi F Gazdar
Apr 30, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C P BelaniR B Natale
May 5, 2005·Journal of the National Cancer Institute·Federico CappuzzoMarileila Varella-Garcia
Jun 16, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·X-T ZhangL Zhang
Jul 7, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Toshimi TakanoTomohide Tamura
Jul 15, 2005·The New England Journal of Medicine·Frances A ShepherdUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jul 15, 2005·The New England Journal of Medicine·Ming-Sound TsaoFrances A Shepherd
Jul 19, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·E H TanUNKNOWN GLOB 2 group

❮ Previous
Next ❯

Citations

Aug 11, 2010·Cancer Chemotherapy and Pharmacology·Athanasios G PallisVassilis Georgoulias
Jan 27, 2012·Cancer Chemotherapy and Pharmacology·Takashi KobayashiNariaki Ohura
Oct 12, 2012·Cancer Chemotherapy and Pharmacology·Chi-Lu ChiangYu-Chin Lee
Sep 16, 2011·International Journal of Clinical Oncology·Yusuke OkumaMasahiko Shibuya
Jan 12, 2013·Targeted Oncology·Nicolas Girard
Jul 22, 2011·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Dolores IslaHenrik W Finnern
Jul 4, 2012·Pathology Oncology Research : POR·Gábor RubovszkyIstván Láng
Feb 22, 2011·Advances in Therapy·N MollbergR Salgia
Aug 25, 2011·Nature Reviews. Clinical Oncology·Tony S K Mok
Jul 25, 2013·Nature Reviews. Clinical Oncology·Cesare Gridelli
Oct 15, 2011·The New England Journal of Medicine·Michael LanutiMari Mino-Kenudson
May 27, 2011·The New England Journal of Medicine·Thomas J Smith, Bruce E Hillner
Apr 11, 2013·Cancer Biotherapy & Radiopharmaceuticals·Liang GuoHong Zhong
Oct 15, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A F Gazdar
Jan 18, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B Glimelius, M Lahn
Feb 9, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J C SoriaD Khayat
Feb 18, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E BriaD Giannarelli
Feb 24, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B J PaessensA Ihbe-Heffinger
May 26, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B CoudertUNKNOWN SATURN Investigators
Jun 10, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C TibaldiG J Peters
Sep 24, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T BrodowiczUNKNOWN Central European Cooperative Oncology Group (CECOG)
Nov 1, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H HayashiK Nakagawa
Jul 10, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M TakedaK Nakagawa
Sep 13, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A InoueUNKNOWN North-East Japan Study Group
Apr 6, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C ObasajuC P Belani
Sep 21, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S RamalingamUNKNOWN FORTIS-M Study Investigators
Oct 5, 2010·Japanese Journal of Clinical Oncology·Nagahiro SaijoYi-Long Wu
Nov 8, 2011·Japanese Journal of Clinical Oncology·Akito HataTadashi Ishida
Feb 7, 2013·Current Opinion in Oncology·Cesare Gridelli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved